International Stem Cell Corporation

International Stem Cell Corporationverified

ISCO

Price:

$0.14

Market Cap:

$1.12M

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cell...[Read more]

Industry

Biotechnology

IPO Date

2007-05-01

Stock Exchange

OTC

Ticker

ISCO

The ROE as of December 2025 (TTM) for International Stem Cell Corporation (ISCO) is 3.33%

According to International Stem Cell Corporation’s latest financial reports and current stock price. The company's current ROE is 3.33%. This represents a change of -111.86% compared to the average of -28.08% of the last 4 quarters.

International Stem Cell Corporation (ISCO) Historical ROE (quarterly & annually)

How has ISCO ROE performed in the past?

The mean historical ROE of International Stem Cell Corporation over the last ten years is -43.64%. The current 3.33% ROE has changed -107.63% with respect to the historical average. Over the past ten years (40 quarters), ISCO's ROE was at its highest in in the September 2017 quarter at 1.16%. The ROE was at its lowest in in the June 2016 quarter at -1111.91%.

Quarterly (TTM)
Annual

Average

-43.64%

Median

-13.01%

Minimum

-294.04%

Maximum

150.42%

International Stem Cell Corporation (ISCO) ROE by Quarter and Year

Discovering the peaks and valleys of International Stem Cell Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 838.53%

Maximum Annual ROE = 150.42%

Minimum Annual Increase = -1224.46%

Minimum Annual ROE = -294.04%

Quarterly (TTM)
Annual
YearROEChange
20245.32%-104.59%
2023-115.93%-1224.46%
202210.31%-54.52%
202122.67%-65.38%
202065.47%-56.47%
2019150.42%-279.07%
2018-84.00%-71.43%
2017-294.04%838.53%
2016-31.33%-81.05%
2015-165.31%-95.75%

International Stem Cell Corporation (ISCO) Average ROE

How has ISCO ROE performed in the past?

The current ROE of International Stem Cell Corporation (ISCO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-33.43%

5-year avg

-2.43%

10-year avg

-43.64%

International Stem Cell Corporation (ISCO) ROE vs. Peers

How is ISCO’s ROE compared to its peers?

International Stem Cell Corporation’s ROE is greater than Biocure Technology Inc. (-17.50%), less than Evofem Biosciences, Inc. (7.90%), less than Chia Tai Enterprises International Limited (10.83%), less than Marizyme, Inc. (48.42%), less than Biomind Labs Inc. (3.21%), less than Biora Therapeutics, Inc. (12.18%), less than NovelStem International Corp. (39.17%), less than Unity Biotechnology, Inc. (0%), less than DATATRAK International, Inc. (353.64%), less than Vaccinex, Inc. (662.54%),

Build a custom stock screener for International Stem Cell Corporation (ISCO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like International Stem Cell Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

International Stem Cell Corporation (ISCO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like International Stem Cell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is International Stem Cell Corporation's ROE?

How is the ROE calculated for International Stem Cell Corporation (ISCO)?

What is the highest ROE for International Stem Cell Corporation (ISCO)?

What is the 3-year average ROE for International Stem Cell Corporation (ISCO)?

What is the 5-year average ROE for International Stem Cell Corporation (ISCO)?

How does the current ROE for International Stem Cell Corporation (ISCO) compare to its historical average?